Latest News of CRS
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 12% Weekly Dip Following COO Resignation
By Yahoo! Finance | 1 week ago
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP
By Yahoo! Finance | 1 month ago
GSK reports positive outcomes from two Phase III trials of treatment for CRSwNP
By Yahoo! Finance | 1 month ago
CRISPR Therapeutics AG (CRSP): the Most Oversold Pharma Stock to Buy According to Analysts
By Yahoo! Finance | 1 month ago
CRISPR (CRSP) Upgraded to Outperform by Evercore, Price Target Raised to $99
By Yahoo! Finance | 1 month ago
Corsair Gaming Inc (CRSR) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...
By Yahoo! Finance | 2 months ago